Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil versus standard haemostatic treatment in cardiovascular surgery
2006-000028-15Phase 4Completed
- Sponsor
- Takeda
- Start
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tachosil in perioperative bleeding and Bleeding (2 arms), sponsored by Takeda. Primary endpoint: Proportion of patients achieving haemostasis after 3 minutes. Started Nov 2006; status: completed.
02
Drugs
tachosil
03
Conditions
perioperative bleedingBleeding
Beyond the preview
Go deeper on 2006-000028-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000028-15.